767 related articles for article (PubMed ID: 30249543)
41. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
42. [Chinese herbal medicine Fuzheng Huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/Smads signaling pathway].
Wang QL; Tao YY; Shen L; Cui HY; Liu CH
Zhong Xi Yi Jie He Xue Bao; 2012 May; 10(5):561-8. PubMed ID: 22587979
[TBL] [Abstract][Full Text] [Related]
43. TGF-β1 mediated Smad signaling pathway and EMT in hepatic fibrosis induced by Nano NiO in vivo and in vitro.
Zhang Q; Chang X; Wang H; Liu Y; Wang X; Wu M; Zhan H; Li S; Sun Y
Environ Toxicol; 2020 Apr; 35(4):419-429. PubMed ID: 31737983
[TBL] [Abstract][Full Text] [Related]
44. Dicliptera Chinensis polysaccharides target TGF-β/Smad pathway and inhibit stellate cells activation in rats with dimethylnitrosamine-induced hepatic fibrosis.
Zhang X; Zhang J; Jia L; Xiao S
Cell Mol Biol (Noisy-le-grand); 2016 Jan; 62(1):99-103. PubMed ID: 26828995
[TBL] [Abstract][Full Text] [Related]
45. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.
Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW
J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597
[TBL] [Abstract][Full Text] [Related]
46. Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-β1 Expression and Autophagy.
Mao Y; Zhang S; Yu F; Li H; Guo C; Fan X
Int J Mol Sci; 2015 Sep; 16(9):21911-30. PubMed ID: 26378522
[TBL] [Abstract][Full Text] [Related]
47. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
48. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
[TBL] [Abstract][Full Text] [Related]
49. [Geniposide inhibits hepatic fibrosis and hepatic stellate cell activation through blocking the TGF-β1/Smad signaling pathway].
Zhou LH; Chen X
Sheng Li Xue Bao; 2022 Apr; 74(2):217-224. PubMed ID: 35503069
[TBL] [Abstract][Full Text] [Related]
50. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis.
Su DN; Wu SP; Xu SZ
Stem Cell Res Ther; 2020 Sep; 11(1):395. PubMed ID: 32928296
[TBL] [Abstract][Full Text] [Related]
51. Suberoylanilide hydroxamic acid (SAHA) inhibits transforming growth factor-beta 2-induced increases in aqueous humor outflow resistance.
Fujimoto T; Inoue-Mochita M; Iraha S; Tanihara H; Inoue T
J Biol Chem; 2021 Sep; 297(3):101070. PubMed ID: 34389355
[TBL] [Abstract][Full Text] [Related]
52. Effect of alprostadil on myocardial fibrosis in rats with diabetes mellitus via TGF-β1/Smad signaling pathway.
Tu JH; Xu Y; Dai Y; Dang L
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9633-9641. PubMed ID: 31773714
[TBL] [Abstract][Full Text] [Related]
53. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling.
Shen N; Li X; Zhou T; Bilal MU; Du N; Hu Y; Qin W; Xie Y; Wang H; Wu J; Ju J; Fang Z; Wang L; Zhang Y
J Ethnopharmacol; 2014 Nov; 157():161-70. PubMed ID: 25267579
[TBL] [Abstract][Full Text] [Related]
54. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
Lu J; Zhang J; Wang Y; Sun Q
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
[TBL] [Abstract][Full Text] [Related]
55. Semen Brassicae ameliorates hepatic fibrosis by regulating transforming growth factor-β1/Smad, nuclear factor-κB, and AKT signaling pathways in rats.
Cao S; Zheng B; Chen T; Chang X; Yin B; Huang Z; Shuai P; Han L
Drug Des Devel Ther; 2018; 12():1205-1213. PubMed ID: 29785090
[TBL] [Abstract][Full Text] [Related]
56. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
57. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
58. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
59. Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs.
Peng J; Li X; Feng Q; Chen L; Xu L; Hu Y
Exp Biol Med (Maywood); 2013 Jun; 238(6):668-77. PubMed ID: 23918878
[TBL] [Abstract][Full Text] [Related]
60. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
